Bafna Pharmaceuticals Ltd Financial Statements

Bafna Pharmaceuticals Ltd Balance Sheet

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 57.70 23.70 23.70 22.70
Preference capital -- -- -- --
Reserves (6.60) (4.60) 14.30 20
Net worth 51.10 19.10 37.90 42.70
Minority interest
Debt 3.02 46.20 46.50 82.40
Deferred tax liabilities (net) -- 6.18 5.11 2.92
Total liabilities 54.20 71.30 88.90 127
Fixed assets 35.20 37.10 44.90 48.60
Intangible assets
Investments -- -- -- 16.90
Deferred tax asset (net) -- -- -- --
Net working capital 10.50 31.50 41 59.30
Inventories 11.40 9.28 10.70 16.70
Inventory Days 98.10 78.10 82.60 94.10
Sundry debtors 6.03 24.80 24.30 53.80
Debtor days 51.80 209 188 302
Other current assets 10.20 45.60 55.60 39.60
Sundry creditors (13) (40) (29) (24)
Creditor days 108 333 221 134
Other current liabilities (4.60) (8.70) (21) (27)
Cash 8.48 2.71 2.95 2.66
Total assets 54.20 71.30 88.90 127

Invest wise with Expert advice

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp